INS and diabetes mellitus: Benfluorex used to be a clinical diabetes medicine by activating HNF4α (Figure S7A, Supporting Information), which also improved levels of insulin and FFA affected by atorvastatin treatment, as well as fasting glucose (Figure 7B,C).